Tarina 24 Fe NDC 50102-224

NDC codes

FDA NDC Directory

Product NDC (as listed)50102-224Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50102-0224Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50102-224-23	50102022423	3 POUCH in 1 CARTON (50102-224-23) / 1 BLISTER PACK in 1 POUCH (50102-224-21) / 1 KIT in 1 BLISTER PACKMarketed from Jun 15, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tarina 24 Fe
Generic name (nonproprietary): norethindrone acetate and ethinyl estradiol and ferrous fumarate
Dosage form: Kit
Labeler: Afaxys Pharma, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207504
Marketing start: Jun 15, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 50102-224_d26d48bb-0073-49c8-8f9d-ad35a3162653SPL ID d26d48bb-0073-49c8-8f9d-ad35a3162653SPL set ID 557fa655-c40f-4ecb-bd18-4820c7e15e4bRxCUI 259176, 1358762, 1359117, 2107008

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N450102022423 followed by a unit qualifier and the quantity

Package 50102-0224-23. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 1, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Tarina 24 Fe is indicated for use by women to prevent pregnancy [see Clinical Studies (14) ] . The efficacy of Tarina 24 Fe in women with a body mass index (BMI) of greater than 35 kg/m 2 has not been evaluated. Tarina 24 Fe is a combination of norethindrone acetate, a progestin, and ethinyl estradiol, an estrogen, indicated for use by women to prevent pregnancy. ( 1 ) The efficacy of Tarina 24 Fe in women with a body mass index (BMI) of greater than 35 kg/m 2 has not been evaluated. ( 1 , 8.8 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207504

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207504
Product	Strength	Form · route	Labeler	Product NDC
Aurovela 24 Fenorethindrone acetate and ethinyl estradiol and ferrous fumarate	—	Kit	Aurobindo Pharma Limited	65862-934